105 related articles for article (PubMed ID: 12660919)
1. Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner.
Promadej N; Costello C; Wernett MM; Kulkarni PS; Robison VA; Nelson KE; Hodge TW; Suriyanon V; Duerr A; McNicholl JM
J Infect Dis; 2003 Apr; 187(7):1053-63. PubMed ID: 12660919
[TBL] [Abstract][Full Text] [Related]
2. Identification of HIV-1 specific T lymphocyte responses in highly exposed persistently seronegative Chinese.
Liu HW; Hong KX; Ma J; Yuan L; Liu S; Chen JP; Zhang YZ; Ruan YH; Xu JQ; Shao YM
Chin Med J (Engl); 2006 Oct; 119(19):1616-21. PubMed ID: 17042974
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine Study.
Cao H; Kaleebu P; Hom D; Flores J; Agrawal D; Jones N; Serwanga J; Okello M; Walker C; Sheppard H; El-Habib R; Klein M; Mbidde E; Mugyenyi P; Walker B; Ellner J; Mugerwa R;
J Infect Dis; 2003 Mar; 187(6):887-95. PubMed ID: 12660934
[TBL] [Abstract][Full Text] [Related]
4. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
5. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
6. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.
Pinto LA; Sullivan J; Berzofsky JA; Clerici M; Kessler HA; Landay AL; Shearer GM
J Clin Invest; 1995 Aug; 96(2):867-76. PubMed ID: 7635981
[TBL] [Abstract][Full Text] [Related]
7. Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2.
McGettigan JP; Koser ML; McKenna PM; Smith ME; Marvin JM; Eisenlohr LC; Dietzschold B; Schnell MJ
Virology; 2006 Jan; 344(2):363-77. PubMed ID: 16226782
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individuals.
Kebba A; Kaleebu P; Rowland S; Ingram R; Whitworth J; Imami N; Gotch F
J Infect Dis; 2004 May; 189(9):1705-13. PubMed ID: 15116309
[TBL] [Abstract][Full Text] [Related]
10. Correlation between HIV-Specific CD8 cell production of interferon- gamma and plasma levels of HIV RNA in perinatally infected pediatric populations.
Borkowsky W; Zhan MX; Chen SH; Ilmet T; Kaul A; Chandwani S; Rigaud M; Essajee S; Gruber C; Freedman A; Krasinski K
J Infect Dis; 2004 Aug; 190(4):722-6. PubMed ID: 15272400
[TBL] [Abstract][Full Text] [Related]
11. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects.
Goh WC; Markee J; Akridge RE; Meldorf M; Musey L; Karchmer T; Krone M; Collier A; Corey L; Emerman M; McElrath MJ
J Infect Dis; 1999 Mar; 179(3):548-57. PubMed ID: 9952360
[TBL] [Abstract][Full Text] [Related]
12. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
13. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
[TBL] [Abstract][Full Text] [Related]
14. HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand.
Sriwanthana B; Hodge T; Mastro TD; Dezzutti CS; Bond K; Stephens HA; Kostrikis LG; Limpakarnjanarat K; Young NL; Qari SH; Lal RB; Chandanayingyong D; McNicholl JM
AIDS Res Hum Retroviruses; 2001 May; 17(8):719-34. PubMed ID: 11429112
[TBL] [Abstract][Full Text] [Related]
15. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 and AIDS: what are protective immune responses?
Beattie T; Rowland-Jones S; Kaul R
J HIV Ther; 2002 May; 7(2):35-9. PubMed ID: 12553686
[TBL] [Abstract][Full Text] [Related]
17. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
[TBL] [Abstract][Full Text] [Related]
18. Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses.
Negri DR; Buffa V; Leone P; Bona R; Borghi M; Carlini F; De Angelis F; Indraccolo S; Ensoli B; Cara A
J Immunol Methods; 2004 Aug; 291(1-2):153-63. PubMed ID: 15345313
[TBL] [Abstract][Full Text] [Related]
19. CD4+ T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women.
Alimonti JB; Koesters SA; Kimani J; Matu L; Wachihi C; Plummer FA; Fowke KR
J Infect Dis; 2005 Jan; 191(1):20-4. PubMed ID: 15592998
[TBL] [Abstract][Full Text] [Related]
20. Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes.
Xu J; Ren L; Huang X; Qiu C; Liu Y; Liu Y; Shao Y
AIDS; 2006 Nov; 20(18):2293-303. PubMed ID: 17117015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
